Skip to main content
Year archive

Heidelberg Pharma AG — 2018 filings

All 38 regulatory filings released by Heidelberg Pharma AG (HPHA) in 2018, sourced directly from the official regulator.

38 Filings
2018 Period
2018 filings (38)
Filing Released Lang
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2018-11-30 English
Heidelberg Pharma Announces Several Presentations of Research Results on ATAC Technology at the ASH Annual Meeting 2018
Regulatory Filings
2018-11-02 English
Q3 statement / Q3 financial report 2017/2018
Interim / Quarterly Report 9M 2018
2018-10-22 German
Heidelberg Pharma AG: Partner Magenta Therapeutics Exercises Option To Further Develop a Target Molecule as Antibody Targeted Amanitin Conjugate
Legal Proceedings Report
2018-10-11 English
Heidelberg Pharma AG: Interim management statement on the first nine months of 2018
Earnings Release 9M 2018
2018-10-11 English
Datum:11.10.2018
Interim / Quarterly Report 9M 2018
2018-10-11 German
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2018-09-28 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2018-09-13 English
Heidelberg Pharma AG: Partner Telix Pharmaceuticals Files Phase III Trial for Kidney Cancer Imaging in Europe
Regulatory Filings
2018-08-23 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2018-07-26 English
Heidelberg Pharma reports on first half-year
Earnings Release H1 2018
2018-07-12 English
Datum:12.07.2018
Interim / Quarterly Report H1 2018
2018-07-12 German
Half-yearly financial report 2017/2018
Interim / Quarterly Report H1 2018
2018-07-12 German
Heidelberg Pharma AG: Heidelberg Pharma Reports Outcome Of Annual General Meeting
AGM Information
2018-06-26 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2018-05-30 English
Datum:11.05.2018
Annual Report FY 2017
2018-05-11 German
Heidelberg Pharma AG: Heidelberg Pharma Presents at Upcoming Conferences and Investor Events
Report Publication Announcement
2018-04-30 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2018-04-30 English
DGAP-DD: Heidelberg Pharma AG deutsch
Director's Dealing
2018-04-24 German
DGAP-DD: Heidelberg Pharma AG deutsch
Director's Dealing
2018-04-24 German
Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2018
Earnings Release Q1 2018
2018-04-12 English
Datum:12.04.2018
Interim / Quarterly Report Q1 2018
2018-04-12 German
Q1 statement / Q1 financial report 2017/2018
Interim / Quarterly Report Q1 2018
2018-04-12 German
Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences
Report Publication Announcement
2018-04-09 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2018-03-29 English
Heidelberg Pharma AG: Heidelberg Pharma announces financial figures for fiscal year 2017 and provides business update
Earnings Release FY 2017
2018-03-22 English
Jahresfinanzbericht 2016/2017
Annual Report FY 2017
2018-03-22 German
Heidelberg Pharma AG : Heidelberg Pharma and Magenta Therapeutics Sign Exclusive Multi-Target Research Agreement for the Development of Antibody Drug Conjugates
Regulatory Filings
2018-03-05 English
Heidelberg Pharma AG : Heidelberg Pharma and Magenta Therapeutics Sign Exclusive Multi-Target Research Agreement for the Development of Antibody Drug Conjugates
M&A Activity
2018-03-05 English
Heidelberg Pharma Signs License Agreement with The University of Texas MD Anderson Cancer Center
Legal Proceedings Report
2018-03-01 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2018-02-28 English
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements
2018-02-06 English
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements
2018-02-05 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2018-01-31 English
Report Publication Announcement 2018
Report Publication Announcement
2018-01-24 English
Hinweis auf Halbjahresfinanzbericht vom 01.12.2017 bis zum 31.05.2018
Report Publication Announcement
2018-01-24 German
Datum:24.01.2018
Report Publication Announcement
2018-01-24 German
Heidelberg Pharma AG and Advanced Proteome Therapeutics Progress Collaborative Program
M&A Activity
2018-01-08 English